285 related articles for article (PubMed ID: 31712117)
1. Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.
Ghafouri-Fard S; Ashrafi Hafez A; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104330. PubMed ID: 31712117
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
4. MALAT1-mediated tumorigenesis.
Liu J; Peng WX; Mo YY; Luo D
Front Biosci (Landmark Ed); 2017 Jan; 22(1):66-80. PubMed ID: 27814602
[TBL] [Abstract][Full Text] [Related]
5. Multiple function of lncRNA MALAT1 in cancer occurrence and progression.
Malakoti F; Targhazeh N; Karimzadeh H; Mohammadi E; Asadi M; Asemi Z; Alemi F
Chem Biol Drug Des; 2023 May; 101(5):1113-1137. PubMed ID: 34918470
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer.
Goyal B; Yadav SRM; Awasthee N; Gupta S; Kunnumakkara AB; Gupta SC
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188502. PubMed ID: 33428963
[TBL] [Abstract][Full Text] [Related]
7. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma.
Liu H; Wang H; Wu B; Yao K; Liao A; Miao M; Li Y; Yang W
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1032-1041. PubMed ID: 28664617
[TBL] [Abstract][Full Text] [Related]
9. An antisense transcript mediates MALAT1 response in human breast cancer.
Gomes CP; Nóbrega-Pereira S; Domingues-Silva B; Rebelo K; Alves-Vale C; Marinho SP; Carvalho T; Dias S; Bernardes de Jesus B
BMC Cancer; 2019 Aug; 19(1):771. PubMed ID: 31382922
[TBL] [Abstract][Full Text] [Related]
10. Growth arrest specific transcript 5 in tumorigenesis process: An update on the expression pattern and genomic variants.
Ghaforui-Fard S; Taheri M
Biomed Pharmacother; 2019 Apr; 112():108723. PubMed ID: 30970522
[TBL] [Abstract][Full Text] [Related]
11. Potential role of RAB6C-AS1 long noncoding RNA in different cancers.
Salavaty A; Motlagh FM; Barabadi M; Cheshomi H; Esmatabadi MJD; Shahmoradi M; Soleimanpour-Lichaei HR
J Cell Physiol; 2018 Jan; 234(1):891-903. PubMed ID: 30076712
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.
Lin N; Yao Z; Xu M; Chen J; Lu Y; Yuan L; Zhou S; Zou X; Xu R
J Exp Clin Cancer Res; 2019 Jun; 38(1):244. PubMed ID: 31174563
[TBL] [Abstract][Full Text] [Related]
13. PCAT1: An oncogenic lncRNA in diverse cancers and a putative therapeutic target.
Ghafouri-Fard S; Dashti S; Taheri M
Exp Mol Pathol; 2020 Jun; 114():104429. PubMed ID: 32220602
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
Pang EJ; Yang R; Fu XB; Liu YF
Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
[TBL] [Abstract][Full Text] [Related]
15. MALAT1 long non-coding RNA in cancer.
Yoshimoto R; Mayeda A; Yoshida M; Nakagawa S
Biochim Biophys Acta; 2016 Jan; 1859(1):192-9. PubMed ID: 26434412
[TBL] [Abstract][Full Text] [Related]
16. Roles of lncRNA-MALAT1 in the Progression and Prognosis of Gliomas.
Ji YL; Kang K; Lv QL; Wang DP
Mini Rev Med Chem; 2024; 24(8):786-792. PubMed ID: 37859309
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
[TBL] [Abstract][Full Text] [Related]
18. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
19. FAL1: A critical oncogenic long non-coding RNA in human cancers.
Lv X; Li Y; Li Y; Li H; Zhou L; Wang B; Zhi Z; Tang W
Life Sci; 2019 Nov; 236():116918. PubMed ID: 31610208
[TBL] [Abstract][Full Text] [Related]
20. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]